Sarepta Therapeutics, Inc. Common Stock (DE) (NASDAQ: SRPT) last traded at $18.79, down 2.24% on the session. The quote above updates while this page is open; the figures below are drawn from Sarepta Therapeutics, Inc. Common Stock (DE)’s own filings and are restated only when a new one is published.
Sarepta Therapeutics, Inc. Common Stock (DE) trades on NASDAQ under the ticker SRPT. Its market capitalisation is $1.98 billion.
Valuation measures for Sarepta Therapeutics, Inc. Common Stock (DE), derived from the latest quote and its most recent SEC filing.
| Market cap | $1.98B |
|---|---|
| Enterprise value | $3.07B |
| Price / sales | 1.01 |
| Price / book | 1.30 |
| Beta | 2.01 |
Trailing-twelve-month figures tagged in Sarepta Therapeutics, Inc. Common Stock (DE)'s XBRL filings with the SEC.
| Revenue (TTM) | $1.97B |
|---|---|
| Net income (TTM) | -$136.72M |
| EPS (TTM) | -$1.60 |
| Gross margin | 51.90% |
| Operating margin | -7.26% |
| Return on equity | -8.95% |
| Cash | $571.15M |
Range and volume for SRPT over the past 52 weeks.
| 52-week high | $25.32 |
|---|---|
| 52-week low | $14.68 |
| Volume | 1.63M |
| Average volume | 3.30M |
| Previous close | $19.22 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.